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A B S T R A C T
Chitosan is a commercially available derivative of chitin that has been extensively studied for its
antimicrobial properties. In order to improve the water solubility and its biological activity, the chemical
modiﬁcation or derivatisation is attempted. In the present investigation, the chitosan prepared from the
cuttlebone of Sepia kobiensis was being chemically modiﬁed by reacting it with orthophosphoric acid so
as to obtain phosphorylated chitosan. Then the chitosan and phosphorylated chitosan were structurally
characterized through FT-IR spectroscopy. Further the antibacterial activity of chitosan and
phosphorylated chitosan was tested against clinically isolated human pathogens (Gram-positive:
Streptococcus sp., Streptococcus pneumoniae and Staphylococcus aureus and Gram-negative: Escherichia
coli,Vibrio cholerae, V. alginolyticus, Vibrio parahaemolyticus, Pseudomonas aeruginosa, Klebsiella pneumo-
niae, Salmonella sp. and Proteus vulgaris) by well diffusion method and the Minimum Inhibitory
Concentration (MIC) was also calculated. The results of the present study suggests that the chitosan and
phosphorylated chitosan has concentration dependent antibacterial activity with variation against
several pathogenic human pathogenic bacterial strains which indicates their possible use as antibacterial
agents.
ã 2015 Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).
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The Class: Cephalopoda which includes the Nautilus, cuttle-
ﬁshes, squids and octopods, is the most advanced class of the
Phylum: Mollusca adapted to a swimming existence. They are
exclusively marine, diverse in form, size and nature [1], and occupy
littoral and benthic to pelagic environments of all the oceans. On
Earth, chitosan is the second most abundant polysaccharide next to
cellulose. As a natural renewable resource, chitosan has a number
of unique properties such as antimicrobial activity, non-toxicity
and biodegradability, which attract scientiﬁc and industrial
interest in the ﬁelds such as biotechnology, pharmaceuticals,
wastewater treatment, cosmetics, agriculture, food science and
textiles [2,3].
Chitosan has a wide inhibition spectrum for not only Gram-
positive and Gram-negative bacteria but also yeast and moulds.
The poor solubility of chitosan has limited its application as a
polysaccharide drug. In order to improve its solubility and* Corresponding author. Fax: +1 4144 243555.
E-mail address: shanpappu48@gmail.com (A. Shanmugam).
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2215-017X/ã 2015 Published by Elsevier B.V. This is an open access article under the Cbioactive potential, the chitosan derivative had been prepared
by incorporating sulfate, phosphate, carboxyl group etc. [4–7] and
their biological activities such as antioxidant activity, antibacterial
activity, anticoagulant activity have also been studied by several
researchers [8]. Subhapradha et al. has prepared phosphorylated
chitosan from the gladius of Sepioteuthis lessoniana from Thondi
coast and studied its in vitro antioxidant activity [4]. Likewise
Barwin Vino et al. has extracted, characterized and studied the in
vitro antioxidant potential of chitosan and sulfated chitosan from
the cuttlebone of Sepia aculeata collected from Cuddalore coast [5].
Further Ngo et al. extensively reviewed the biological effects of
chitosan and its derivatives. There is an ever continuous and urgent
need to discover new antimicrobial compounds with diverse
chemical structures and novel mechanism of action due to the
alarming increase that has been witnessed in the incidence of both
new and reemerging infectious diseases. A further big concern is
the development of resistance to the antibiotics in current clinical
use [9,3]. The purpose of this investigation was to evaluate the
antibacterial potential of chitosan and its water soluble derivative,
phosphorylated chitosan, prepared from the cuttlebone of cuttle-
ﬁsh Sepia kobiensis.C BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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2.1. Collection of animals
The cuttlebones were removed from S. kobiensis purchased
from Mudasalodai (Cuddalore, Tamil Nadu) landing center (lat. 11
500 N; long. 79 770 E) during the period of March–April 2015. The
cuttlebones were washed thoroughly in tap water followed with
distilled water. They were then dried and pulverized using pestle
and mortar for further analysis.
2.2. Extraction of chitin and chitosan
Chitin was extracted from the cuttlebone of Sepia kobiensis and
a chitosan with DDA of 85.55% and molecular weight of 322.04 kDa
was prepared [10].
2.3. Preparation of phosphorylated chitosan
Phosphorylated chitosan was prepared by dissolving 2 g of
chitosan powder with 30 g of urea and 50 ml of N,N-dimethylfor-
mamide (DMF) followed which 5.2 ml of orthophosphoric acid was
added and the mixture was allowed to react at 150 C for 1 h. After
cooling, the reaction mixture was precipitated and washed
thoroughly with methanol and then the residue was re-dissolved
in distilled water. The pH was adjusted to 10– 11 by sodium
hydroxide. The solution was dialyzed against distilled water for
48 h using a 12 000 Da MW cut-off dialysis membrane. Then the
product was lyophilized to get phosphorylated chitosan.
2.4. FT-IR spectral analysis of chitosan and phosphorylated chitosan
FT-IR spectroscopy of solid samples of chitosan and phosphor-
ylated chitosan obtained from the cuttlebone of S. kobiensis were
relied on an AVATAR 330 FT-IR spectrometer. 10 mg of each sample
was mixed with 100 mg of dried potassium bromide (KBr) and
compressed to prepare salt disc (10 mm diameter) for reading the
spectrum further.Fig. 1. FT-IR spectrum of chitosan (A) and phosp2.5. Determination of antibacterial activity by agar well diffusion
method
Eleven species of bacteria (clinical isolates) (Gram-positive:
Streptococcus sp., S. pneumoniae and Staphylococcus aureus; Gram-
negative: E. coli, Vibrio cholerae, V. alginolyticus, V. parahaemolyticus,
Pseudomonas aeruginosa, Klebsiella pneumoniae,Salmonella sp.and
Proteus vulgaris) obtained from the Raja Muthaiah Medical College
Hospital, Annamalai University, Annamalai Nagar, Tamil Nadu, India
were used as test organisms. Nutrient broth was prepared and
sterilized in an autoclave at 15 lbs pressure for 15 min. Individual
species of bacteria were inoculated in the sterile nutrient broth and
incubated at 37 C for 24 h. Mueller Hinton Agar (MHA, Himedia)
medium was prepared, sterilized in an autoclave at 15 lbs pressure
for 15 min and poured into sterile petridishes and incubated at 37 C
for 24 h. The antibacterial activity of the individual bacterial strains
was tested using Agar well diffusion method [9]. 24 h old nutrient
broth cultures of test bacteria were aseptically swabbed on sterile
nutrient agar plates. Wells of 5 mm diameter were made aseptically
in the inoculated plates. The different concentrations of chitosan
(Stock—5 mg/ml in 0.2% Acetic acid) and phosphorylated chitosan
(Stock-5 mg/ml in distilled water), from this stock solution four
different concentrations viz., 25, 50, 75 and 100% prepared were
loaded in the respective wells. Standard (Tetracycline,1 mg/ml) and
Control (0.2% acetic acid) were also loaded into the respectively
labeled wells. The plates were incubated at 37 C for 24 h in upright
position. The experiment was carried out in triplicate and the zone
of inhibition was recorded.
2.6. Determination of the Minimum Inhibitory Concentration (MIC)
The MIC of chitosan and its derivative phosphorylated chitosan
was determined by standard method [11]. In this method, a stock
solution of 100 mg/ml was prepared. This was serially diluted to
obtain various concentrations lying between 5 mg and 100 mg/ml.
0.5 ml of each of the dilutions of different concentrations was
transferred into sterile test tube containing 2 ml of nutrient broth.
To the test tubes, 0.5 ml of test organisms previously adjusted to a
concentration of 105 cells/ml was then introduced. A set of testhorylated chitosan (B) from Sepia kobiensis.
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tubes and control were then incubated at 37 C for 18 h. The tubes
were then studied for the visible signs of growth or turbidity after
the period of incubation. The lowest concentration of chitosan and
phosphorylated chitosan that inhibited the growth of bacteria was
considered as the Minimum Inhibitory Concentration.
2.7. Statistical analysis
Data obtained from the experiments (in triplicate) on the
inhibitory effects of chitosan and phosphorylated chitosan were
analyzed by one-way analysis of variance (ANOVA) using SPSS
software (16 version) followed by Duncun’s multiple range test
(DMRT) and standard error . ‘P’ values at <0.05 were considered
for describing the signiﬁcant levels.
3. Results
3.1. FT-IR spectroscopy
The FT-IR spectra of chitosan and phosphorylated chitosan are
depicted in Fig. 1A&B, respectively. The peak at 3435.37 cm1
corresponds to H-bonded NH2 and OH stretching. The peaks at
2921.94 cm1 and 2852.95 cm1 correspond to aliphatic CH
stretching. The peak obtained at 1640.62 cm1 corresponds to
the amide stretching of C¼O and the band at 1020.99 cm1
attributes to COC stretching vibrations. In phosphorylated
chitosan the peak found at 1386.30 cm1 attributes to P¼O
stretching which conﬁrms the phosphorylation.Fig. 2. Antibacterial activity of 3.2. Antibacterial activity
The chitosan and phosphorylated chitosan from S. kobiensis
showed good antibacterial activity against almost all pathogenic
bacteria (Figs. 2 and 3). The antibacterial activity was found to be
concentration dependent. At the same time the activity was absent
in negative control (Table 1). In 100% concentration, the highest
inhibition zone of 17 mm diameter clear zone was noticed against
P. vulgaris in chitosan (Fig. 2) and 16 mm clear zone recorded
against Staphylococcus aureus in phosphorylated chitosan (Fig. 3).
The lowest inhibition zone of 13 mm 7 mm was observed against S.
pneumoniae in chitosan and Proteus vulgaris in phosphorylated
chitosan respectively. In 75% concentration, chitosan showed
highest activity of 15 mm inhibition zone against P. vulgaris, P.
aeruginosa; whereas phosphorylated chitosan showed 12 mm in S.
aureus. The lowest activity with 12 mm inhibition zone was
observed against K. pneumonia and E. coli in chitosan and 7 mm
against Salmonella sp. in phosphorylated chitosan.
In 50% concentration, the maximum activity of 14 mm was
recorded against P. vulgaris and P. aeruginosa in chitosan and 9 mm
against S. aureus in phosphorylated chitosan. The lowest 10 mm
inhibition zone against S. pneumoniae in chitosan; whereas
phosphorylated chitosan reported no activity in all the bacterial
strains tested except Staphylococcus aureus. In 25% concentration,
the maximum activity of 13 mm was recorded against P. vulgaris, P.
aeruginosa in chitosan and 7 mm in phosphorylated chitosan
against S. aureus.The lowest 9 mm against S. pneumoniae in
chitosan and in phosphorylated chitosan minimum of 7 mm
against Staphylococuus aureus and no activity was noticed in all
other strains. The positive control tetra cycline showed thechitosan from S. kobiensis.
Fig. 3. Antibacterial activity of phosphorylated chitosan from S. kobiensis.
Table 1
Antibacterial activity of chitosan and phosphorylated chitosan from Sepia kobiensis.
S. No Bacterial strain Chitosan (%) Phosphorylated chitosan (%) +C C
25 50 75 100 25 50 75 100
1 Vibrio cholerae ++ ++ ++ +++ – – + ++ +++ –
2 Pseudomonas aeruginosa ++ ++ ++ +++ – – – – +++ –
3 Klebsiella pneumoniae + ++ ++ ++ – – – + ++ –
4 V. alginolyticus + ++ ++ ++ – – – + +++ –
5 Staphylococcus aureus ++ ++ ++ ++ + + ++ +++ +++ –
6 V. parahaemolyticus ++ ++ ++ ++ – – ++ ++ +++ –
7 Streptococcus sp. + ++ ++ +++ – – – – +++ –
8 S. pneumoniae + + ++ ++ – – – – +++ –
9 Salmonella sp. + ++ ++ ++ – – + + +++ –
10 E. coli + ++ ++ ++ – – – – +++ –
11 Proteus vulgaris ++ ++ ++ +++ – – – + +++ –
+C Positive control; C Negative control; (–) No activity, (+) Weak activity (7–10 mm dia.), (++) Good activity (11–15 mm dia.), (+++) Very good activity (above 16 mm dia.).
*The statistical signiﬁcance: P values 0.05 (DMRT).
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against K. pneumoniae.
3.3. Minimum Inhibitory Concentration (MIC)
MIC values for chitosan against bacterial strains such as V.
cholerae, P. aeruginosa, K. pneumoniae, V. alginolyticus, S. aureus, V.
parahaemolyticus, Streptococcus sp., S. pneumoniae, Salmonella sp.,
E. coli and P. vulgaris were recorded as 60, 60, 100, 80, 80, 100, 60,
100, 80, 80 and 50 mg/ml, respectively. Whereas in phosphorylated
chitosan, the MIC for V. cholerae, K. pneumoniae, V. alginolyticus, S.
aureus, V. parahaemolyticus, Salmonella sp. and P. vulgaris wasrecorded as 80, 100, 100, 50, 80, 100 and 100 mg/ml, respectively
(Table 2).
4. Discussion
The overall goal of the present investigation is not only to
compare the ability of antibacterial activity of chitosan and its
water soluble phosphorylated chitosan prepared from the cuttle-
bone of S. kobiensis but also to know whether derivatization of
chitosan improves the antibacterial activity. The results of the
present investigation clearly showed (Tables 1 & 2) that good
antibacterial activity was exhibited by chitosan than the
Table 2
MIC of chitosan and phosphorylated chitosa n from Sepia kobiensis.
Bacterial strains Chitosan (mg/ml) Phosphorylated chitosan (mg/ml)
100 80 60 50 40 20 10 5 100 80 60 50 40 20 10 5
Vibrio cholerae – – * + ++ +++ +++ +++ – * + ++ ++ +++ +++ +++
Pseudomonas aeruginosa – – * + ++ +++ +++ +++ + ++ ++ +++ +++ +++ +++ +++
Klebsiella pneumoniae * + ++ +++ +++ +++ +++ +++ * + ++ ++ +++ +++ +++ +++
V. alginolyticus – * + ++ +++ +++ +++ +++ * + ++ ++ +++ +++ +++ +++
Staphylococcus aureus – * + ++ +++ +++ +++ +++ – – – * + ++ +++ +++
V. parahaemolyticus * + + ++ +++ +++ +++ +++ – * + ++ ++ +++ +++ +++
Streptococcus sp. – – * + + ++ +++ +++ + ++ ++ +++ +++ +++ +++ +++
S. pneumoniae * + ++ ++ +++ +++ +++ +++ + ++ ++ +++ +++ +++ +++ +++
Salmonella sp. – * + + ++ +++ +++ +++ * + ++ ++ +++ +++ +++ +++
E. coli – * + + ++ +++ +++ +++ + ++ ++ +++ +++ +++ +++ +++
Proteus vulgaris – – – * + ++ +++ +++ * + ++ ++ +++ +++ +++ +++
*The statistical signiﬁcance: P values 0.05 (DMRT).
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pathogens and the derivatization did not improve the activity. But
at the same time the activity was found to be different with
different bacterial strains.
In recent years, great attention has been paid to study the
bioactivity of natural products due to their potential pharmaco-
logical utilization. The rationale of searching for drugs from marine
environment from the fact that marine plants and animals have
adapted to all sorts of habitats in the marine environment and
these are constantly under tremendous selection pressure includ-
ing competition for space, predation, surface fouling and
reproduction. Many of these organisms are showing antimicrobial
properties. Although most of the antibacterial agents isolated from
marine sources have not been active enough to compete with
classical anti-microbials obtained from microorganisms [12–14],
majority of marine organisms are yet to be screened for discovering
useful antibiotics.
The FT-IR spectrum of chitosan from the gladius of S. lessoniana
recorded the peak at 3409.07 cm1 corresponds to H-bonded NH2
& OH stretching. The peaks at 2921.24 cm1 and 2852.70 cm1
correspond to aliphatic CH stretching. The peak obtained at
1654.79 cm1 corresponds to the amide stretching of C¼O and the
bands at 1106.85 and 1020.63 cm1 attributed to the COC
stretching vibration mode. In phosphorylated chitosan the peak
found at 1381.44 corresponds to P¼O stretching. The peaks found
at 1084.28 and 561.86 are due to P-OH group [12]. In the present
investigation, the FT-IR spectrum of chitosan from S. kobiensis also
reported the peaks more or less at the same wave length, as in S.
lessoniana i.e., the peaks corresponding to H-bonded NH2 and OH
stretching at 3435.37 cm1, aliphatic CH stretching at 2921.94 cm1
and 2852.95, amide stretching of C¼O at 1640.62 cm1 and
COC stretching vibration modes at 1020.99 cm1. In phos-
phorylated chitosan the peak found at 1386.30 cm1 attributes to
P¼O stretching, as also noticed (1380 cm1) in the phosphorylated
chitosan in S. lessoniana [12].
In an earlier study, 89% of deacetylated chitosan and its
oligosaccharides showed more effective activity against pathogens
than that of non-pathogens except in the case of lactic acid bacteria
[15]. Further, chitosan from S. lessoniana reported the maximum
inhibition of 14 mm and against S. aureus at the highest
concentration of 5 mg/ml and minimum inhibition of 8 mm
against K. pnemoniae and V. cholera [8]. But in the present
investigation in 100% concentration, the maximum inhibition zone
(17 mm diameter clear zone) was noticed against P. vulgaris in
chitosan, 16 mm clear zone against S. aureus in phosphorylated
chitosan. The lowest inhibition zone of 13 mm was observed
against S. pneumoniae in chitosan and 7 mm against P. vulgaris in
the case of phosphorylated chitosan. The antibacterial activity of
chitosan against all pathogenic strains was found concentrationdependent. This result is consistent with the work of Jeon et al. [16]
who have also reported the increased antibacterial activity with
increase in the concentration of chitosan.
Generally, the inhibitory activity of chitosan towards bacteria is
considered in terms of its chemical and structural properties. As a
polymeric macromolecule, chitosan is unable to pass the outer
membrane of bacteria (since this membrane functions as an
efﬁcient outer permeability barrier against macromolecules).
Therefore, direct access to intracellular parts of the cell by chitosan
is unlikely. A key feature of the chitosan is its positive charge of the
amino group at C-2 below its pKa (pH, 6.3). This creates a
polycationic structure, which can be expected to interact with the
predominantly anionic components (lipopolysaccharides and
proteins) of the bacterial surface [17]. However, it was shown
that the biological activity of chitosan signiﬁcantly depends on its
physico-chemical properties such as molecular weight and
molecular fraction of glucosamine units in the polymer chain
(i.e., the degree of chitosan N-deacetylation), pH of chitosan
solution and of course, the target microorganism [18,8].
Phosphorylated chitosan from S. lessoniana recorded the
maximum inhibition of 13 mm against V. cholerae and S. pnemoniae
at the concentration of 5 mg/ml and minimum inhibition of 7 mm
against V. cholera, S. aureus, S. pnemoniae and P. vulgaris at the
concentration of 1.25 mg/ml [12]. When compared to this ﬁnding,
the present investigation showed a higher antibacterial activity in
100% concentration with the maximum inhibition zone of 16 mm
clear zone recorded against S. aureus in phosphorylated chitosan
and lowest inhibition zone of 7 mm against P. vulgaris.
The exact mechanism of antimicrobial action of chitosan
derivatives is still unknown, but different mechanisms have been
proposed. The water-soluble chitosan derivative is said to be
increasing the permeability of cell membrane and ultimately
disrupted bacterial cell membrane with the release of cellular
contents [19]. The water-insoluble chitosan molecules also
precipitate and stack on the microbial cell surface, thereby forming
an impervious layer around the cell and blocking the channels,
which are crucial for living cells. Such a layer is expected to prevent
the transport of essential solutes and may also destabilize the cell
wall beyond repair thereby causing severe leakage of cell
constituents and ultimately cell death [20,8] which would be
the possible reason for the antibacterial activity of chitosan and
phosphorylated chitosan from the internal bone of S. kobiensis.
Estimation of Minimum Inhibitory Concentration (MIC) is
widely used in the comparative testing of new drugs. In clinical
laboratories it is used to establish the susceptibility of organisms
that is required for clinical management [21]. In the present
investigation, the MIC values for chitosan and phosphorylated
chitosan from S. kobiensis against bacterial strains such as V.
cholerae, P. aeruginosa, K. pneumoniae, V. alginolyticus, S. aureus, V.
30 A. Shanmugam et al. / Biotechnology Reports 9 (2016) 25–30parahaemolyticus, Streptococcus sp., S. pneumoniae, Salmonella sp.,
E. coli & P. vulgaris and V. cholerae, K. pneumoniae, V. alginolyticus, S.
aureus, V. parahaemolyticus, Salmonella sp. & P. vulgaris were
reported as 60, 60, 100, 80, 80, 100, 60, 100, 80, 80 & 50 mg/ml and
80, 100, 100, 50, 80, 100 & 100 mg/ml, respectively.
In conclusion, the present investigation reveals that the
chitosan from S. kobiensis inhibits the growth of all the tested
pathogenic bacterial strains when compared to the phosphorylat-
ed chitosan which indicates that the chitosan may contain a broad
range of antibacterial activity. Additionally the present study
brings out the possibility of using the internal bone of cuttleﬁsh
that is thrown as waste at home and seafood processing industries
are very good and promising source for antibacterials. However,
further investigation involving clinical experiments is needed for
its use as a drug for human beings.
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